NO20044497L - Torr pulver sammensetninger - Google Patents

Torr pulver sammensetninger

Info

Publication number
NO20044497L
NO20044497L NO20044497A NO20044497A NO20044497L NO 20044497 L NO20044497 L NO 20044497L NO 20044497 A NO20044497 A NO 20044497A NO 20044497 A NO20044497 A NO 20044497A NO 20044497 L NO20044497 L NO 20044497L
Authority
NO
Norway
Prior art keywords
dry powder
powder compositions
inhalation
treatment
storage stability
Prior art date
Application number
NO20044497A
Other languages
English (en)
Norwegian (no)
Inventor
Trevor Charles Roche
Pallav Arvind Bulsara
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20044497L publication Critical patent/NO20044497L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20044497A 2002-04-13 2004-10-21 Torr pulver sammensetninger NO20044497L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0208608.0A GB0208608D0 (en) 2002-04-13 2002-04-13 Composition
PCT/GB2003/001542 WO2003088943A1 (en) 2002-04-13 2003-04-10 Dry powder compositions

Publications (1)

Publication Number Publication Date
NO20044497L true NO20044497L (no) 2004-11-15

Family

ID=9934855

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044497A NO20044497L (no) 2002-04-13 2004-10-21 Torr pulver sammensetninger

Country Status (19)

Country Link
US (1) US20050244340A1 (https=)
EP (1) EP1494644A1 (https=)
JP (1) JP2005530733A (https=)
KR (1) KR20040099436A (https=)
CN (1) CN1658839A (https=)
AR (1) AR039409A1 (https=)
AU (1) AU2003217073A1 (https=)
BR (1) BR0309114A (https=)
CA (1) CA2481467A1 (https=)
GB (1) GB0208608D0 (https=)
IL (1) IL164420A0 (https=)
IS (1) IS7500A (https=)
MX (1) MXPA04010080A (https=)
NO (1) NO20044497L (https=)
PL (1) PL373294A1 (https=)
RU (1) RU2004130439A (https=)
TW (1) TW200404008A (https=)
WO (1) WO2003088943A1 (https=)
ZA (1) ZA200408245B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337816B2 (en) 2001-09-17 2012-12-25 Glaxo Group Limited Dry powder medicament formulations
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
EP1643974A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Inhalable pharmaceutical formulations comprising a sugar ester
EP1643973A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Pharmaceutical formulations comprising magnesium stearate
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
WO2006066907A1 (en) * 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
MX2007009656A (es) * 2005-02-10 2007-11-07 Glaxo Group Ltd Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma.
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
PL2046787T3 (pl) 2006-08-01 2011-10-31 Glaxo Group Ltd Związki pirazolo[3,4-b]pirydynowe i ich zastosowanie jako inhibitory PDE4
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
AU2014261538A1 (en) * 2013-04-29 2015-12-10 Sanofi Sa Inhalable pharmaceutical compositions and the inhaler devices containing them
AU2015296024A1 (en) * 2014-08-01 2017-03-23 Luxena Pharmaceuticals, Inc. Palonosetron formulations and uses thereof
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
CN110237373B (zh) * 2018-03-08 2023-06-02 润生药业有限公司 一种生产用于联合用药的药物载体的装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
AU591152B2 (en) * 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
JPH04220268A (ja) * 1990-12-19 1992-08-11 Olympus Optical Co Ltd バルーンカテーテル
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
PT994887E (pt) * 1997-07-03 2003-04-30 Elan Drug Delivery Ltd Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
GB9916316D0 (en) * 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0020616D0 (en) * 2000-08-21 2000-10-11 Quadrant Holdings Cambridge Particulates
JP2004526674A (ja) * 2000-12-01 2004-09-02 バテル・メモリアル・インスティテュート 液体処方物中における生体分子の安定化のための方法
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
TW200404008A (en) 2004-03-16
BR0309114A (pt) 2005-02-01
AR039409A1 (es) 2005-02-16
KR20040099436A (ko) 2004-11-26
GB0208608D0 (en) 2002-05-22
IL164420A0 (en) 2005-12-18
IS7500A (is) 2004-10-11
MXPA04010080A (es) 2004-12-13
RU2004130439A (ru) 2005-06-10
CN1658839A (zh) 2005-08-24
ZA200408245B (en) 2007-03-28
EP1494644A1 (en) 2005-01-12
JP2005530733A (ja) 2005-10-13
PL373294A1 (en) 2005-08-22
WO2003088943A1 (en) 2003-10-30
US20050244340A1 (en) 2005-11-03
AU2003217073A1 (en) 2003-11-03
CA2481467A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
NO20044497L (no) Torr pulver sammensetninger
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
WO2005041921A3 (en) Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
NO20044496L (no) Torr pulver innhaleringssammensetning
WO2005025541A3 (en) Dry powder composition comprising a benzodiazepine for pulmonary inhalation
WO2004093848A3 (en) Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
WO2002083079A3 (en) Aerosol compositions containing formoterol for delivery to the lungs via nebulization
ECSP088577A (es) Enmascaramiento del sabor de polvos
ATE556704T1 (de) Pulverinhalator-formulierungen
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
MX2010005036A (es) Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
WO2005041922A3 (en) Composition
NO20074854L (no) Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel
WO2005004854A3 (fr) Utilisation de la betaine pour le traitement des arterites
NO20051463L (no) Inhaleringssammensetninger med hoy legemiddelandel
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
IL168308A (en) Compositions containing roflumilast and formoterol
WO2006019894A3 (en) Nebulized pharmaceutical compositions for the treatment of bronchial disorders
SE0103210D0 (sv) New formulations and use thereof
IL168307A (en) Compositions containing roflumilast and (r,r)-formoterol
WO2007054139A3 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
PT1490049E (pt) Citalopram para o tratamento da pre3ssao sanguinia elevada.
BR0303347A (pt) Formulações de aerossol contendo ésteres de derivados de 3,17-diidroxi estratieno para deposição pulmonar
TW200633701A (en) Thioether derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application